Trade

with

Rosetta Genomics Ltd
(NASDAQ: ROSG)
AdChoices
3.00
-0.13
-4.15%
After Hours :
-
-
-

Open

3.16

Previous Close

3.13

Volume (Avg)

24.59k (77.59k)

Day's Range

3.00-3.16

52Wk Range

2.35-6.69

Market Cap.

-

Dividend Rate ( Yield )

-

Beta

-2.85

Shares Outstanding

11.23M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 405.00k

    • Net Income

    • -12.90M

    • Market Cap.

    • -

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1,800.00

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -2.85

    • Forward P/E

    • -4.00

    • Price/Sales

    • 40.65

    • Price/Book Value

    • 1.70

    • Price/Cash flow

    • -2.21

      • EBITDA

      • -12.85M

      • Return on Capital %

      • -53.07

      • Return on Equity %

      • -57.67

      • Return on Assets %

      • -53.07

      • Book Value/Share

      • 1.77

      • Shares Outstanding

      • 11.23M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Outperform
        • 1 Year Price Target

        • 7.75

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -1.00

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -68.60

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • -23.15

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -36.42

            • 42.70

            • Pre-Tax Margin

            • -1,800.00

            • 11.63

            • Net Profit Margin

            • -1,800.00

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • -113.80

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -6,650.30

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 13.82

              • 1.23

              • Quick Ratio

              • 13.79

              • 0.76

              • Interest Coverage

              • -598.48

              • 5.98

              • Leverage Ratio

              • 1.09

              • 2.16

              • Book Value/Share

              • 1.77

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -2.18

                • 31.85

                • P/E Ratio 5-Year High

                • -157.35

                • 325.07

                • P/E Ratio 5-Year Low

                • -1.06

                • 154.73

                • Price/Sales Ratio

                • 39.22

                • 2.21

                • Price/Book Value

                • 1.63

                • 2.88

                • Price/Cash Flow Ratio

                • -2.21

                • 18.15

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -57.67

                    (-)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • -53.07

                    (-121.90)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • -57.58

                    (-)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • -

                  • 17.17k

                  • Inventory Turnover

                  • -

                  • 5.07

                  • Asset Turnover

                  • 0.03

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -13.35M
                  Operating Margin
                  -3,295.56
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -2.21
                  Ownership

                  Institutional Ownership

                  8.98%

                  Top 10 Institutions

                  8.72%

                  Mutual Fund Ownership

                  0.23%

                  Float

                  99.97%

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Philadelphia Invmt Ptnrs New Generation

                  •  

                    25,000

                  • 0.00

                  • 0.22

                  • Marketocracy Masters 100 Fund

                  •  

                    1,000

                  • 0.00

                  • 0.01

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • National Asset Management, Inc.

                  •  

                    512,830

                  • +38.95%

                  • 4.57

                  • Wells Fargo Advisors, LLC

                  •  

                    154,122

                  • +2,426.59%

                  • 1.37

                  • Highlander Capital Management LLC

                  •  

                    104,019

                  • -4.59%

                  • 0.93

                  • Susquehanna Financial Group, LLLP

                  •  

                    56,887

                  • +149.24%

                  • 0.51

                  • GRT Capital Partners LLC

                  •  

                    43,000

                  • -9.47%

                  • 0.38

                  • Philadelphia Investment Partners, LLC

                  •  

                    25,000

                  • 0.00%

                  • 0.22

                  • Spark Investment Management LLC

                  •  

                    11,300

                  • -78.27%

                  • 0.10

                  • Nomura Holdings Inc

                  •  

                    10,603

                  • -53.09%

                  • 0.10

                  • Knight Capital Americas LLC

                  •  

                    10,235

                  • -52.30%

                  • 0.09

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  -

                  Style

                  Small Growth

                  Rosetta Genomics Ltd is engaged in the development and commercialization of new diagnostic tests and therapeutics based on a group of genes known as microRNAs.

                  Key People

                  Mr. Kenneth A. Berlin

                  CEO/President

                  Mr. Brian A. Markison

                  Chairman of the Board/Director

                  Ron Kalfus

                  CFO

                  Dr. Eti Meiri

                  Vice President, Divisional

                  David Sidransky,M.D.

                  Director

                  • Rosetta Genomics Ltd

                  • 10 Plaut Street

                  • Rehovot, 76706

                  • ISR.Map

                  • Phone: +972 732220700

                  • Fax: +972 732220701

                  • rosettagenomics.com

                  Incorporated

                  2000

                  Employees

                  45

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: